Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma

Overview of attention for article published in Targeted Oncology, February 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Evaluation of factors predicting the benefit from systemic oncological treatment for severely ill hospitalized patients: a retrospective study

Article in BMC Palliative Care (September 2023)

Evaluation of factors predicting the benefit from systemic oncological treatment for severely ill hospitalized patients: A retrospective study

Preprint in Research Square (July 2023)

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy

Article in Frontiers in Oncology (July 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.